Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct:310:115277.
doi: 10.1016/j.socscimed.2022.115277. Epub 2022 Aug 15.

COVID-19 booster uptake among US adults: Assessing the impact of vaccine attributes, incentives, and context in a choice-based experiment

Shyam Raman  1 , Douglas Kriner  2 , Nicolas Ziebarth  1 , Kosali Simon  3 , Sarah Kreps  4
Affiliations

COVID-19 booster uptake among US adults: Assessing the impact of vaccine attributes, incentives, and context in a choice-based experiment

Shyam Raman et al. Soc Sci Med. 2022 Oct.

Abstract

Objective: Evidence shows that booster shots offer strong protection against the Omicron variant of COVID-19. However, we know little about why individuals would receive a booster compared to the initial decision to vaccinate. We investigate and assess the factors that affect individuals' reported willingness to receive the COVID-19 vaccine booster. This information can aid in tailoring public health messaging to communicate attributes that are associated with individuals' attitudes toward the COVID-19 booster.

Rationale: Existing research provides little insight into whether the same factors that affect Americans' likelihood of accepting initial vaccination against COVID-19 also affect booster uptake. Our experiment also examines the influence of contextual information about a novel variant on willingness to receive a booster.

Methods: We administered a conjoint experiment (N = 2740 trials) in a survey of fully vaccinated US adults that had not yet received a COVID-19 booster (N = 548) to assess the impact of varied vaccine attributes on willingness to receive a booster.

Results: The most important factors associated with higher willingness to receive a booster were efficacy, manufacturer, and the size of a financial incentive. Protection duration and protection against future variants vs. only current variants had modest influence. A contextual prime reporting that some public health experts believe the Omicron variant is more contagious, but less lethal than those previously seen, significantly increased favorability toward boosters. This provides potential motivation and guidance for vaccination campaigns to emphasize these variant-specific traits.

Conclusion: With several vaccines with varying degrees of efficacy available to consumers, emphasizing boosters with a high efficacy would likely improve attitudes toward boosters. Financial incentives and predispositions toward manufacturers also matter. Concerns about more contagious variants may spur uptake, even if such variants are less lethal.

Keywords: Booster; COVID-19; Conjoint experiment; Public acceptance; Vaccine.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Marginal Means of Booster Acceptance by COVID-19 Vaccine Attributes Note: Marginal means obtained from OLS regression in Table 2, Model (1).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abbasi J. Studies suggest COVID-19 vaccine boosters save lives. JAMA. 2022;327:115. doi: 10.1001/jama.2021.23455. - DOI - PubMed
    1. Abu-Raddad L.J., Chemaitelly H., Ayoub H.H., AlMukdad S., Yassine H.M., Al-Khatib H.A., Smatti M.K., Tang P., Hasan M.R., Coyle P., Al-Kanaani Z., Al-Kuwari E., Jeremijenko A., Kaleeckal A.H., Latif A.N., Shaik R.M., Abdul-Rahim H.F., Nasrallah G.K., Al-Kuwari M.G., Butt A.A., Al-Romaihi H.E., Al-Thani M.H., Al-Khal A., Bertollini R. Effect of mRNA vaccine boosters against SARS-CoV-2 omicron infection in Qatar. N. Engl. J. Med. 2022;386:1804–1816. doi: 10.1056/NEJMoa2200797. - DOI - PMC - PubMed
    1. Bar-On Y.M., Goldberg Y., Mandel M., Bodenheimer O., Freedman L., Alroy-Preis S., Ash N., Huppert A., Milo R. Protection against covid-19 by BNT162b2 booster across age groups. N. Engl. J. Med. 2021;385:2421–2430. doi: 10.1056/NEJMoa2115926. - DOI - PMC - PubMed
    1. Barry C.L., Anderson K.E., Han H., Presskreischer R., McGinty E.E. Change over time in public support for social distancing, mask wearing, and contact tracing to combat the COVID-19 pandemic among US adults, april to november 2020. Am. J. Publ. Health. 2021;111:937–948. doi: 10.2105/ajph.2020.306148. - DOI - PMC - PubMed
    1. Bech M., Kjaer T., Lauridsen J. Does the number of choice sets matter? Results from a web survey applying a discrete choice experiment. Health Econ. 2011;20:273–286. doi: 10.1002/hec.1587. - DOI - PubMed

Substances

Supplementary concepts